Manuel Nistal

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

Garcilaso Riesco‐Eizaguirre, Paula Gutierrez‐Martinez, Miguel Ángel García‐Cabezas et al. · Endocrine Related Cancer · 2006 · 366 citations · Full text

The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

Garcilaso Riesco‐Eizaguirre, Irene Rodrı́guez, Antonio De la Vieja et al. · Cancer Research · 2009 · 257 citations

Lysyl Oxidase–Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas

Héctor Peinado, Gema Moreno‐Bueno, David Hardisson et al. · Cancer Research · 2008 · 200 citations

Expression of Ghrelin and Its Functional Receptor, the Type 1a Growth Hormone Secretagogue Receptor, in Normal Human Testis and Testicular Tumors

Francisco Gaytán, M. L. Barreiro, J. Eduardo Caminos et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 195 citations · Full text

Spermatogenesis, Human Growth, Normal Human Testis +19

Physiological Androgen Insensitivity of the Fetal, Neonatal, and Early Infantile Testis Is Explained by the Ontogeny of the Androgen Receptor Expression in Sertoli Cells

H Chemes, Rodolfo A. Rey, Manuel Nistal et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 193 citations · Full text